PEDRINA SALINAS: Open Payments
NPI 1477857746 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,089 in 102 payments from 27 companies in 2025. Trend: 2023 $44 · 2024 $1,219 · 2025 $2,089
Food & beverage: $2,089
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 14 | $317 |
| Novo Nordisk Inc | 13 | $256 |
| Amgen Inc. | 16 | $215 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $153 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $147 |
| RECORDATI_RARE_DISEASES_INC. | 7 | $143 |
| Mannkind Corporation | 3 | $122 |
| Antares Pharma, Inc. | 5 | $114 |
| SANOFI-AVENTIS U.S. LLC | 4 | $76 |
| Tandem Diabetes Care, Inc. | 3 | $68 |
Products named: JARDIANCE, Ozempic, Kerendia, ISTURISA, AFREZZA, XYOSTED, MOUNJARO, EVENITY.
Industry payments across NC — which companies pay providers there.
